Zimmer Biomet
869 hedge funds and large institutions have $21.2B invested in Zimmer Biomet in 2017 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 293 increasing their positions, 284 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
869
Holders Change
+51
Holders Change %
+6.23%
% of All Funds
19.74%
Holding in Top 10
16
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.67%
% of All Funds
0.36%
New
115
Increased
293
Reduced
284
Closed
60
Calls
$113M
Puts
$65.5M
Net Calls
+$47.7M
Net Calls Change
-$52.8M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$562M |
| 2 |
Goldman Sachs
New York
|
+$144M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$129M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$123M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$81.4M |
Top Sellers
| 1 |
GCM
Glenview Capital Management
New York
|
-$369M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$183M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$174M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$119M |
| 5 |
JP
Jana Partners
New York
|
-$97.5M |